AGP Picks
View all

Perspectify logo Perspectify News

Labels

Read articles from across the media landscape with news outlet bias labels for added context. Learn about labels.

Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
What the EU partnership could mean for Canada for work, study, and trade

What the EU partnership could mean for Canada for work, study, and trade

Building Finance on Digital Rails: Reto Marx on Sygnum's Regulated Path into Future Finance

Building Finance on Digital Rails: Reto Marx on Sygnum's Regulated Path into Future Finance

CA next bank Brings Avaloq’s New Mobile App to Swiss Clients

CA next bank Brings Avaloq’s New Mobile App to Swiss Clients

CA next bank deploys Avaloq’s new mobile banking app 

CA next bank deploys Avaloq’s new mobile banking app 

CA Next Bank Becomes First Swiss Bank to Launch Avaloq’s New Mobile Banking App

CA Next Bank Becomes First Swiss Bank to Launch Avaloq’s New Mobile Banking App

Swiss lower house of parliament signs off Mercosur trade deal

Swiss lower house of parliament signs off Mercosur trade deal

QNu Labs sees ₹4,000-5,000 crore quantum-safe market opportunity over next 5 years

QNu Labs sees ₹4,000-5,000 crore quantum-safe market opportunity over next 5 years

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)

Andorra and Liechtenstein: two European microstates facing the same problem—abortion while remaining Catholic

Andorra and Liechtenstein: two European microstates facing the same problem—abortion while remaining Catholic

Swiss upper house of parliament backs Mercosur trade deal

Swiss upper house of parliament backs Mercosur trade deal

Explainer: The EU’s Proposed ‘Associate Membership’ for Canada

Explainer: The EU’s Proposed ‘Associate Membership’ for Canada

We may look back on this as the week Canada began to take its fate into its own hands

We may look back on this as the week Canada began to take its fate into its own hands

Full list: Names of 31 countries whose citizens can enter Germany without visa to live with parents

Full list: Names of 31 countries whose citizens can enter Germany without visa to live with parents

China lists 48 countries whose visa-free entry arrangement will end in December 2026

China lists 48 countries whose visa-free entry arrangement will end in December 2026

Liechtenstein parliament backs abortion initiative, but prince has the last word
Kazakhstan and Liechtenstein strengthen bilateral ties

Kazakhstan and Liechtenstein strengthen bilateral ties

Geneva to Lugano? Switzerland could allow foreign airlines to run domestic routes

Geneva to Lugano? Switzerland could allow foreign airlines to run domestic routes

Google removes product carousels in  Europe

Google removes product carousels in Europe

Heightened Risks to Companies from Spread of Forced Labor Import Bans

Heightened Risks to Companies from Spread of Forced Labor Import Bans

EU-Canada agreement infuriates Trump

EU-Canada agreement infuriates Trump

Sign up for:

Liechtenstein Business Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Liechtenstein Business Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.